What is the most appropriate treatment for a patient with Crohn's disease, segmental colonic inflammation, and multiplex stenosis in the terminal ileum?

Diagnostic Modalities for Crohn's Disease Relapse

For a patient with suspected Crohn's disease relapse after 2 years of remission, the appropriate diagnostic workup includes: 1) ileocolonoscopy, 3) MR-enterography, and 4) stool calprotectin. 1

Rationale for Each Diagnostic Test

Ileocolonoscopy (Correct Choice)

• Ileocolonoscopy with biopsy is the gold standard for evaluating Crohn's disease activity, allowing direct visualization of mucosal inflammation and assessment of disease extent 1
• This modality is essential for defining the presence and severity of morphological disease and predicting clinical course 1
• Segmental colonic and ileal biopsies should be obtained to detect microscopic disease even when mucosa appears normal 1

MR-Enterography (Correct Choice)

• MR-enterography is complementary to ileocolonoscopy for complete small bowel assessment, particularly since up to 20% of Crohn's patients have isolated proximal small bowel disease beyond endoscopic reach 1
• This imaging modality is critical for identifying strictures, assessing their length, and detecting prestenotic dilatation 1
• MRE has equivalent diagnostic accuracy to CT enterography without radiation exposure 1

Stool Calprotectin (Correct Choice)

• Fecal calprotectin serves as a validated surrogate marker for intestinal inflammation, useful for distinguishing active inflammation from functional symptoms 1
• This non-invasive test helps guide treatment decisions and can be used for monitoring disease activity 1
• Calprotectin-driven treatment escalation has been shown to improve endoscopic and quality of life outcomes 1

Stool Cultures (Incorrect Choice)

• While infection should be excluded in any patient with diarrhea, stool cultures are not a primary diagnostic modality for Crohn's disease assessment
• This test is more relevant for ruling out infectious colitis as a differential diagnosis rather than evaluating known Crohn's disease activity

---

Treatment Selection for Multiplex Ileal Stenosis with Colonic Inflammation

D. Early surgical resection of stenotic segments is the most appropriate treatment for this patient with multiplex stenosis in the terminal ileum without prestenotic dilatation and segmental colonic inflammation. 1

Critical Analysis of the Clinical Scenario

This patient presents with:

• Multiple strictures in the terminal ileum (multiplex stenosis)
• Segmental colonic inflammation without stenosis
• No prestenotic dilatation (suggesting non-obstructive but fibrotic disease)
• Disease relapse after 2 years off medication

Why Surgery is the Preferred Option

Evidence Supporting Surgical Intervention

Surgery is the preferred option in patients with localized ileocecal Crohn's disease with obstructive symptoms but no significant evidence of active inflammation 1

• Laparoscopic resection of stricturing, fibrotic disease of the terminal ileum (<40 cm) can be offered as a sound therapeutic option with a benefit and risk profile comparable to medical therapy 1
• In the randomized LIR!C trial comparing infliximab to laparoscopic ileocecal resection for active disease <40 cm, there was no difference in quality of life at 12 months, and serious complications were not different between groups 1
• Over 4 years follow-up, 37% of infliximab-treated patients required resection, whereas only 26% of primarily resected patients needed infliximab 1

Why Anti-TNF Therapy (Option A) is Inappropriate

Anti-TNF therapy is ineffective for established fibrotic strictures 2

• Multiple strictures without prestenotic dilatation suggest predominantly fibrotic rather than inflammatory stenosis 2
• Systemic infliximab has been reported to be ineffective in the treatment of strictures 2, 3
• While anti-TNF agents can induce mucosal healing in inflammatory disease, they cannot reverse established fibrosis 4
• The absence of prestenotic dilatation indicates these are likely chronic, fibrotic strictures rather than acute inflammatory narrowing 1

Why Corticosteroids (Option B) are Inappropriate

• Corticosteroids are indicated for active inflammatory disease, not for fibrotic strictures 1, 5
• The multiplex stenosis without prestenotic dilatation suggests fibrotic disease that will not respond to anti-inflammatory therapy 1
• While the patient has segmental colonic inflammation, the primary pathology requiring intervention is the ileal stricturing disease 1
• Corticosteroids would only address the inflammatory component and would not resolve the mechanical obstruction from strictures 1

Why Azathioprine Monotherapy (Option C) is Inappropriate

• Azathioprine has a slow onset of action (3-6 months) and is ineffective as sole therapy for active disease 1
• This immunomodulator cannot address established fibrotic strictures 1
• Azathioprine is appropriate as adjunctive therapy and for maintenance, not for managing symptomatic stricturing disease 1, 5

Surgical Approach Considerations

Optimal Surgical Technique

Wide lumen stapled ileocolic side-to-side (functional end-to-end) anastomosis is the preferred technique 1

• This configuration has been shown to reduce overall postoperative complications, clinical recurrence, and reoperation rates compared to other anastomotic techniques 1
• A laparoscopic approach is preferred for ileocolic resections where appropriate expertise is available 1

Management of Segmental Colonic Disease

Segmental colectomy is appropriate for patients with a single involved colonic segment 1

• The patient's segmental colonic inflammation can be addressed with segmental resection if symptomatic 1
• However, the primary indication for surgery is the multiplex ileal stenosis 1

Common Pitfalls to Avoid

• Do not attempt medical management of established fibrotic strictures—this delays definitive treatment and risks complications such as complete obstruction 1, 2
• Do not assume all strictures are inflammatory—the absence of prestenotic dilatation and multiple strictures suggest chronic fibrotic disease 1
• Do not use anti-TNF therapy as first-line for stricturing disease—reserve biologics for inflammatory, non-stricturing disease or for postoperative prophylaxis 1, 2
• Ensure surgical backup is available if considering any endoscopic intervention for strictures 1

Alternative Consideration: Stricturoplasty

Stricturoplasty can be used as first-line treatment whenever technically feasible for multiple small bowel strictures 1

• Classical indications include stricturing disease of a large portion of small bowel, previous bowel resection >100 cm, or multiple strictures 1
• In patients with multiple jejunoileal locations, the typical procedure combines small bowel resections and stricturoplasties 1
• However, stricturoplasty of the colon is contraindicated due to bowel wall characteristics and cancer risk 1